Etiological and biological aspects of cigarette smoking in rheumatoid arthritis

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 5, 2009, Pages 364-368

  Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

AhR; Cigarette smoking; Cytokine; Inflammation; Rheumatoid arthritis; Synovial cell; Th17

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CIGARETTE SMOKE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6 ANTIBODY; POLYCYCLIC AROMATIC HYDROCARBON; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNITY; CIGARETTE SMOKING; CYTOKINE PRODUCTION; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; FIBROBLAST; HELPER CELL; HUMAN; NONHUMAN; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYNOVIAL FLUID; SYNOVIOCYTE; TH17 CELL; TOBACCO;

EID: 74849126522     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528110908050364     Document Type: Review

References (64)

1. Short, C.L. The antiquity of rheumatoid arthritis. Arthritis Rheum., 1974, 17, 193-205.
2. Rothschild, B.M.; Turner, K.R.; DeLuca, M.A. Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. Science, 1988, 241, 1498-501.
3. Altschuler, E.L. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning. Lancet, 1999, 354, 1026-7.
4. Abe, T. In Collagen Disease and Rheumatoid Disease ; Miyasaka, N. Ed.; Asakura Press: Tokyo, 2001, pp. 2-5.
5. History of Tobacco Boston University Medical Center, http://academic. udayton.edu/health/syllabi/tobacco/history.htm#newworld.
6. History net, http://www.historian.org/bysubject/tobacco1.htm
7. Balandraud, N.; Roudier, J.; Roudier, C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun. Rev., 2004, 3, 362-7.
8. Cohen, B.J.; Buckley, M.M.; Clewley, J.P.; Jones, V.E.; Puttick, A.H.; Jacoby, R.K. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann. Rheum. Dis., 1986, 45, 832-8.
9. Tingle, A.J.; Allen, M.; Petty, R.E.; Kettyls, G.D.; Chantler, J.K. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann. Rheum. Dis., 1986, 45, 110-4.
10. Nishioka, K.; Maruyama, I.; Sato, K.; Kitaiima, I.; Nakajima, Y.; Osame, M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet, 1989, 1, 441.
11. Trautwein, G.; Seidler, D; Schulz, L.C.; Drommer, W.; Weiss, R.; Böhm, K.H. Immunopathology and pathogenesis of chronic erysipelas polyarthritis of swine. Z. Rheumatol., 1976, 35, 217-39.
12. Ebringer, A.; Rashid, T.; Wilson, C. Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases. Scand. J. Rheumatol., 2003, 32, 2-11.
13. Lydyard, P.; Tsoulfa, G.; Sharif, M.; Broker, B.; Smith, M.; Rook, G.A. Immunity to heat shock proteins in rheumatoid arthritis. Clin. Exp. Rheumatol., 1990, Suppl 5, 69-74.
14. Hida, S.; Miura, N.N.; Adachi, Y.; Ohno, N. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice. J. Autoimmun., 2005, 25, 93-101.
15. Harrison, B.J.; Silman, A.J.; Wiles, N.J.; Scott, D.J.; Symmons, D.P. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum., 2001, 44, 323-30.
16. Tuomi, T.; Heliovaara, M.; Palosuo, T.; Aho, K. Smoking, lung function, and rheumatoid factors. Ann. Rheum. Dis., 1990, 49, 753-6.
17. Hutchinson, D.; Shepstone, L.; Moots, R.; Lear, J.T.; Lynch, M.P. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann. Rheum. Dis., 2001, 60, 223-7.
18. Karlson, E.W.; Lee, I.M.; Cook, N.R.; Manson, J.E.; Buring, J.E.; Hennekens, C.H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum., 1999, 42, 910-7.
19. Peschken, C.A.; Esdaile, J.M. Rheumatic diseases in North America's indigenous peoples. Semin. Arthritis. Rheum., 1999, 28, 368-91.
20. Padyukov, L.; Silva, C.; Stolt, P.; Alfredsson, L.; Klareskog, L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum., 2004, 50, 3085-92.
21. Jaakkola, J.J.; Gissler, M. Maternal smoking in pregnancy as a determinant of rheumatoid arthritis and other inflammatory polyarthropathies during the first 7 years of life. Int. J. Epidemiol., 2005, 34, 664-71.
22. Luck, W; Nau, H; Hansen, R; Steldinger, R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther., 1985, 8, 384-95.
23. Firestein, G.S.; Alvaro-Gracia. J.M.; Maki, R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol., 1990, 144, 3347-53.
24. Arend, W.P.; Dayer, J.M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum., 1995, 38, 151-60.
25. Szekanecz, Z.; Koch, A.E.; Kunkel, S.L.; Strieter, R.M. Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention. Drugs Aging, 1998, 12, 377-90.
26. Zwerina, J.; Redlich, K.; Polzer, K.; Joosten, L.; Krönke, G.; Distler, J.; Hess. A.; Pundt, N.; Pap, T.; Hoffmann, O.; Gasser, J.; Scheinecker, C.; Smolen, J.S.; van den Berg, W.; Schett, G. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 11742-7.
27. Buchan, G.; Barrett, K.; Turner, M.; Chantry, D.; Maini, R.N.; Feldmann, M. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin. Exp. Immunol., 1988, 73, 449-55.
28. Shimozato, O; Watanabe, N.; Goto, M.; Kobayashi, Y. Cytokine production by SV40-transformed adherent synovial cells from rheumatoid arthritis patients. Cytokine, 1996, 8, 99-105.
29. Niki, Y.; Yamada, H.; Kikuchi, T.; Toyama, Y.; Matsumoto, H.; Fujikawa, K.; Tada, N. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J. Immunol., 2004, 172, 577-84.
30. Lipsky, P.E.; van der Heijde, D.M.; St Clair, E.W.; Furst, D.E.; Breedveld, F.C.; Kalden, J.R.; Smolen, J.S.; Weisman, M.; Emery, P.; Feldmann, M.; Harriman, G.R.; Maini, R.N. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med., 2000, 343, 1594-62.
31. Moreland, L.W.; Margolies, G.; Heck, L.W. Jr.; Saway, A.; Blosch, C.; Hanna, R.; Koopman, W.J. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J. Rheumatol., 1996, 23, 1849-55.
32. Furst, D.E. Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin. Therap., 2004, 26, 1960-75.
33. Choy, E.H.; Isenberg, D.A.; Garrood, T.; Farrow, S.; Ioannou, Y.; Bird, H.; Cheung, N.; Williams, B.; Hazleman, B.; Price, R.; Yoshizaki, K.; Nishimoto, N.; Kishimoto, T.; Panayi, G.S. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum., 2002, 46, 3143-50.
34. Rusznak, C.; Mills, P.R.; Devalia, J.L.; Sapsford, R.J.; Davies, R.J.; Lozewicz, S. Effect of cigarette smoke on the permeability and IL-1 beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol., 2000, 23, 530-6.
35. Ito, K.; Lim, S.; Caramori, G.; Chung, K.F.; Barnes, P.J.; Adcock, I.M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J., 2001, 15, 1110-2.
36. Gaschler, G.J.; Zavitz, C.C.; Bauer, C.M.; Skrtic, M.; Lindahl, M.; Robbins, C.S.; Chen, B.; Stämpfli, M, R. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am. J. Respir. Cell Mol. Biol., 2008, 38, 218-26.
37. Flouris, A.D.; Metsios G.S.; Carrillo A.E.; Jamurtas A.Z.; Gourgoulianis K.; Kiropoulos T.; Tzatzarakis M.N.; Tsatsakis A.M.; Koutedakis Y. Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am. J. Respir. Crit. Care Med., 2009, 79, 1029-33.
38. Tamaki, A.; Hayashi, H.; Nakajima, H.; Takii, T.; Katagiri, D.; Miyazawa, K.; Hirose, K.; Onozaki, K. Cigarette smoke condensate upregulates the gene and protein expression of proinflammatory cytokines in human fibroblast-like synoviocyte line. Interferon Cytokine Res., 2008, 28, 509-21.
39. th Annual Meeting of Pharmaceutical Society of Japan, 2009, 27, p. 168.
40. H17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med., 2007, 13, 139-145.
41. Fouse, L.A.; Wright, J.F.; Dunussi-Joannopoulos, K.; Collins, M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol. Rev., 2008, 226, 87-103.
42. Park, H.; Li, Z.; Yang, X.O.; Chang, S.H.; Nurieva, R.; Wang, Y.H.; Wang, Y.; Hood, L, ; Zhu, Z.; Tian, Q.; Dong, C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol., 2005, 6, 1133-41.
43. Lubberts, E.; Joosten, L.A.; Oppers, B.; van den Bersselaar, L.; Coenen-de Roo, C.J.; Kolls, J.K.; Schwarzenberger, P.; van de Loo, F.A.; van den Berg, W.B. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collageninduced arthritis. J. Immunol., 2001, 167, 1004-13.
44. Zhang, Z.; Zheng, M.; Bindas, J.; Schwarzenberger, P.; Kolls, J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis., 2006, 12, 382-8.
45. McKinley L.; Alcorn, J.F.; Peterson, A.; Dupont, R.B.; Kapadia, S.; Logar, A.; Henry, A.; Irvin, C.G.; Piganelli, J.D.; Ray, A.; Kolls, J.K. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol., 2008, 181, 4089-97.
46. Matusevicius, D.; Kivisäkk, P.; He, B.; Kostulas, N.; Ozenci, V.; Fredrikson, S.; Link, H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler., 1999, 5, 101-4.
47. Kotake, S.; Udagawa, N.; Takahashi, N.; Matsuzaki, K.; Itoh, K.; Ishiyama, S.; Saito, S.; Inoue, K.; Kamatani, N.; Gillespie, M.T.; Martin, T.J.; Suda, T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest., 1999, 103, 1345-52.
48. Pène, J.; Chevalier, S.; Preisser, L.; Vénéreau, E.; Guilleux, M.H.; Ghannam, S.; Molès, J.P.; Danger, Y.; Ravon, E.; Lesaux, S.; Yssel, H, ; Gascan, H. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol., 2008, 180, 7423-30.
49. Bush, K.A.; Farmer, K.M.; Walker, J.S.; Kirkham, B.W. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum., 2002, 46, 802-5.
50. Nakae, S.; Saijo, S.; Horai, R.; Sudo, K.; Mori, S.; Iwakura, Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 5986-90.
51. Nakae, S.; Nambu, A.; Sudo, K.; Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol., 2003, 171, 6173-7.
52. Ruth, J.H.; Shahrara, S.; Park, C.C.; Morel, J.C.; Kumar, P.; Qin, S.; Koch, A.E. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab. Invest., 2003, 83, 579-88.
53. Hirota, K.: Yoshitomi, H.; Hashimoto, M.; Maeda, S.; Teradaira, S.; Sugimoto, N.; Yamaguchi, T.; Nomura, T.; Ito, H.; Nakamura, T.; Sakaguchi, N.; Sakaguchi, S. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med., 2007, 204, 2803-12.
54. Nistala, K.; Moncrieffe, H.; Newton, K.R.; Varsani, H.; Hunter, P.; Wedderburn, L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum., 2008, 58, 875-87.
55. Yamada, H.; Nakashima, Y.; Okazaki, K.; Mawatari, T.; Fukushi, J.I.; Kaibara, N.; Hori, A.; Iwamoto, Y.; Yoshikai, Y. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis., 2008, 67, 1299-304.
56. Acosta-Rodriguez, E. V.; Napolitani G.; Lanzavecchia, A.; Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol., 2007, 8, 942-9.
57. Veldhoen, M.; Hirota, K.; Westendorf, A.M.; Buer, J.; Dumoutier, L.; Renauld, J.C.; Stockinger, B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature, 2008, 453, 106-9.
58. Quintana, F.J.; Basso, A.S.; Iglesias, A.H.; Korn, T.; Farez, M.F.; Bettelli, E.; Caccamo, M.; Oukka, M.; Weiner, H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature, 2008, 453, 65-71.
59. Kobayashi, S.; Okamoto, H.; Iwamoto, T.; Toyama, Y.; Tomatsu, T.; Yamanaka, H.; Momohara, S. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology, 2008, 47, 1317-22.
60. Kasai, A.; Hiramatsu, N.; Hayakawa, K.; Yao, J.; Maeda, S.; Kitamura, M. High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res., 2006, 66, 7143-50.
61. Itoh, Y.; Hayashi, H.; Miyazawa, K.; Kojima, S.; Akahoshi, T.; Onozaki K. 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERalpha) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERalpha. J. Immunol., 2007, 178, 3059-66.
62. Itoh, Y.; Hayashi, H.; Xu, J.; Takii, T.; Miyazawa, K.; Ariga, H.; Akahoshi, T.; Waguri-Nagaya, Y.; Otsuka, T.; Okamoto, T.; Onozaki, K. Dihydrotestosterone inhibits tumor necrosis factor alpha induced interleukin-1alpha mRNA expression in rheumatoid fibroblast-like synovial cells. Biol. Pharm. Bull., 2007, 30, 1140-3.
63. Yoshino, S.; Sagai, M. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles. J. Pharmacol. Exp. Ther., 1999, 29, 524-9.
64. Hart, J.E.; Laden, F.; Puett, R.C.; Costenbader, K.H.; Karlson, E.W. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ. Health Perspect., 2009, 117, 1065-9.